Winton Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-190,079
Closed -$3.97M 1075
2022
Q3
$3.97M Buy
190,079
+48,290
+34% +$1.01M 0.26% 68
2022
Q2
$2.94M Buy
+141,789
New +$2.52M 0.16% 171
2020
Q4
Sell
-61,045
Closed -$1.49M 1575
2020
Q3
$1.49M Sell
61,045
-102,522
-63% -$2.21M 0.05% 655
2020
Q2
$2.93M Buy
163,567
+30,347
+23% +$399K 0.08% 469
2020
Q1
$1.08M Sell
133,220
-120,257
-47% -$1.37M 0.03% 772
2019
Q4
$3.35M Buy
+253,477
New +$3.07M 0.05% 607

Other funds holding CVET

Winton Group's CVET Position: Q4 2022 in Review

Winton Group sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 190,079 shares — an estimated $3.97M sold.

Winton Group first reported a position in CVET in Q4 2019 and held it in 6 quarters. The position peaked at $3.97M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Winton Group reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Winton Group sold 190,079 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $3.97M.
  • Winton Group first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Winton Group's Covetrus, Inc. Common Stock position peaked at $3.97M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Winton Group's 13F filing for Q4 2022, filed 14 Feb 2023.